Arterial hypertension and smoking in pregnant women in the Valencian Community: maternal and neonatal outcomes.

Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Morales-Suarez-Varela, M.
- Peraita-Costa, I.
- Guerrero Cervera, B
- Llopis-Morales, A.
- Botella Juan, L
Abstract
OBJECTIVE: Hypertension and smoking during pregnancy have been linked to various adverse maternal and fetal outcomes. The objective of this work is to study how the smoking influences the development of hypertension, its effects on the pregnant woman, and on the newborn. MATERIALS AND METHODS: An observational study in two phases was carried out: the descriptive first phase allows characterization of the sample and the analytical second phase is a case-control nested in a retrospective cohort corresponding to pregnancy. RESULTS: A total of 712 women were included in the study. Of the 672 (94.4%) non-hypertensive women, 533 (79.3%) were non-smoking and 139 (20.7%) smoking. For the 40 (5.6%) hypertensive women, 30 (75.0%) were non-smoking and 10 (25.0%) smoking. The prevalence of hypertension was of 5.6%. Women who quit smoking before pregnancy saw a reduced risk of hypertension. For women who smoke during pregnancy, those of younger ages, with a normal body mass index, who are primiparous, employed and with a low-medium level of education have higher risk of hypertension. The risk of hypertension according to the level of physical activity during leisure time follows a "U" shape, with those who perform light physical activity at the lowest risk of hypertension. Hypertensive women have a higher risk of small for gestational age newborns. Smoking does not pose an additional risk for adverse outcomes once hypertension is diagnosed. CONCLUSIONS: Future studies should aim to determine the role of smoking habit in the appearance of hypertension in pregnancy in order to establish adequate intervention guidelines that may aid in reducing the prevalence of hypertension.
Copyright © 2023 Sociedad Española de Médicos de Atención Primaria (SEMERGEN). Publicado por Elsevier España, S.L.U. All rights reserved.
Datos de la publicación
- ISSN/ISSNe:
- 1138-3593, 1578-8865
- Tipo:
- Article
- Páginas:
- 102171-102171
- Factor de Impacto:
- 0,204 SCImago ℠
- Cuartil:
- Q3 SCImago ℠
MEDICINA DE FAMILIA-SEMERGEN Ediciones Doyma S.A.
Documentos
- No hay documentos
Filiaciones
Filiaciones no disponibles
Keywords
- Embarazo; Hipertensión; Hypertension; Madre; Maternal; Newborn; Outcomes; Pregnancy; Recién nacido; Resultados; Smoking; Tabaquismo
Proyectos asociados
PAPEL DEL FACTOR DE CRECIMIENTO PLACENTARIO EN EL MANEJO DE LA PREECLAMPSIA NO SEVERA: ESTUDIO ALEATORIZADO
Investigador Principal: ALFREDO JOSÉ PERALES MARÍN
PI15/01935 . INSTITUTO DE SALUD CARLOS III . 2016
ESTUDIO DE FASE IIB/IIIA, MULTICÉNTRICO, ALEATORIZADO, DE GRUPOS PARALELOS, CON ENMASCARAMIENTO DOBLE Y CONTROLADO CON PLACEBO PARA EVALUAR LA EFICACIA Y LA SEGURIDAD DE AMAG-423, UN FRAGMENTO AB DE ANTICUERPOS ANTIDIGOXINA, EN PACIENTES EMBARAZADAS CON PREECLAMPSIA GRAVE.
Investigador Principal: ALFREDO JOSÉ PERALES MARÍN
AMAG-423-201 . 2019
ENSAYO MULTICÉNTRICO, ABIERTO, ALEATORIZADO, DE DOSIS ÚNICA, CONTROLADO, DE XOMA 213 ADMINISTRADO POR VÍA INTRAVENOSA A MUJERES DESPUÉS DEL PARTO PARA LA SUPRESIÓN DE LA LACTANCIA.
Investigador Principal: ALFREDO JOSÉ PERALES MARÍN
X213220
Estudio clínico prospectivo para la realización de un cribado molecular para la detección precoz de preeclampsia en el primer trimestre de embarazo.
Investigador Principal: ALFREDO JOSÉ PERALES MARÍN
IGX1-PRE-CS-20-11 . 2022
Prevención de la obesidad de por vida mediante la identificación temprana de factores de riesgo, pronóstico e intervención.
Investigador Principal: ISAURO ROGELIO MONFORT ORTIZ
FCS-OBE-CS-22-3 . 2023
Estudio clínico para entender la contribución materna en el origen y causas de la preeclampsia mediante secuenciación a nivel de célula única.
Investigador Principal: ISAURO ROGELIO MONFORT ORTIZ
FCS-EMB-TG-23-02 . 2023
Estudio molecular de la interfase materna-fetal de forma prospectiva a la aparición de preeclampsia mediante tecnología de célula única.
Investigador Principal: BEATRIZ MARCOS PUIG
FCS-IMF-TG-23-03 . 2023
Cita
Morales M,Peraita I,Guerrero B,Llopis A,Botella L,Marcos B. Arterial hypertension and smoking in pregnant women in the Valencian Community: maternal and neonatal outcomes. Semergen. 2023. 50. (4):p. 102171-102171.